Diclofenac Epolamine
Product Images NDC 50436-3727

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Diclofenac Epolamine (NDC 50436-3727). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Unit Dose Services, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Diclofenac 01)

FDA Label Image

Figure 1 And 2 (Diclofenac 02)

Figure 1 And 2 (Diclofenac 02)
The text describes two figures showing the levels of pain relief achieved by patients at day 3 and at the end of a 14-day study. The figures are labeled "Figure 1" and "Figure 2" and depict the percentage of patients achieving various levels of pain relief. The text also includes a section on the percent improvement from baseline.*
FDA Label Image

Figure 3 And 4 (Diclofenac 03)

FDA Label Image

Label Image (Lbl504363727)

Label Image (Lbl504363727)
This appears to be a product description for a topical pain relief medication containing diclofenac. The medication is dispensed in a system with a concentration of 1.3% diclofenac epolamine. The brand name mentioned is TEVA PHARY USA. The Lot number is 500000800 and it is only for prescription use, indicated with RX ONLY. There are multiple Noc numbers mentioned, 50436-3727-1, 5003637271, which may refer to the same or different products with slightly varying concentrations. The text also includes some references to manufacturing details.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.